Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo

Albert A. De Vera, Pranav Gupta, Zining Lei, Dan Liao, Silpa Narayanan, Qiuxu Teng, Sandra E. Reznik, Zhe Sheng Chen

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences